Executive Summary
A massive wave of 96 8-K filings on January 26, 2026, signals heightened corporate activity focused on critical market events, with ~52 filings (54%) disclosing Entry into Material Definitive Agreements (Item 1.01), suggesting a surge in M&A, partnerships, and financing deals across tech, biotech, energy, and SPACs. Approximately 30 filings (31%) report officer changes (Item 5.02), indicating widespread leadership transitions potentially tied to strategic shifts or turmoil. Critical bearish outliers include iRobot Corp's bankruptcy/receivership (Item 1.03, materiality 10/10, bearish sentiment) and Liminatus Pharma's delisting notice (Item 3.01, materiality 10/10, bearish), amid neutral sentiment in 95/96 filings and medium risk levels dominant. Multi-item high-materiality filings like Indivior PLC (9/10, changes in control + equity mods) and USA Rare Earth (7/10, multi-events) point to transformative restructurings. No quantitative period-over-period trends, insider trades, or guidance disclosed across filings limits granular comparisons, but patterns imply dilution risks from ~15 Item 3.02 unregistered equity sales and debt via Item 2.03 in ~10 cases. Portfolio implications: overweight M&A catalysts in small-caps, underweight distressed names; monitor for follow-on filings on deal terms.
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from January 22, 2026.
Investment Signals(12)
- IonQ, Inc.β(BULLISH)β²
Multi-item filing with Item 1.01 material agreement + Item 2.02 results + Reg FD (materiality 7/10), potential quantum tech partnership signaling growth
- Leidos Holdings, Inc.β(BULLISH)β²
Item 1.01 material agreement + Reg FD (materiality 7/10, 2MB filing), defense sector strategic deal likely accretive
- Orgenesis Inc.β(BULLISH)β²
Item 1.01 agreement + Item 3.02 equity sales (materiality 7/10), biotech financing for expansion despite dilution
- USA Rare Earth, Inc.β(BULLISH)β²
Multi-item incl. Item 1.01 agreement, Item 2.02 results, Item 3.02 equity (materiality 7/10, 28MB), rare earth supply chain catalyst
- ImmunityBio, Inc.β(BULLISH)β²
Item 1.01 material agreement (materiality 8/10), immuno-oncology partnership potential
- Graham Corpβ(BULLISH)β²
Item 1.01 agreement + Reg FD (materiality 7/10), energy/industrial contract win opportunity
- Armata Pharmaceuticals, Inc.β(BULLISH)β²
Item 1.01 material agreement (materiality 8/10), phage therapy deal upside
- DevvStream Corpβ(BULLISH)β²
Item 1.01 agreement + Reg FD (materiality 8/10), carbon credit/tech financing bullish
- VisionWave Holdings, Inc.β(BULLISH)β²
Item 1.01 agreement + Reg FD (materiality 8/10), vision tech M&A signal
- Stoke Therapeutics, Inc.β(BULLISH)β²
Item 1.01 agreement + Item 2.03 obligation (materiality 8/10), neuro biotech funding
- TD SYNNEX CORPβ(BULLISH)β²
Item 1.01 agreement (materiality 8/10), IT distribution mega-deal potential
- Super Micro Computer, Inc.β(BULLISH)β²
Item 1.01 agreement + Item 5.08 nominations (materiality 7/10, 38MB), AI server expansion
Risk Flags(8)
- iRobot Corp/Bankruptcyβ[HIGH RISK]βΌ
Item 1.03 bankruptcy/receivership + Item 1.02 termination + changes in control (materiality 10/10, bearish sentiment), total wipeout risk
- Liminatus Pharma/Delistingβ[CRITICAL RISK]βΌ
Item 3.01 notice of delisting/failure to meet standards (materiality 10/10, bearish), liquidity crisis
- Indivior PLC/Control Changeβ[HIGH RISK]βΌ
Multi-items incl. Item 5.01 changes in control, Item 3.02 equity sales, Item 3.03 rights mods (materiality 9/10, high risk), takeover/dilution
- Orgenesis Inc/Dilutionβ[MEDIUM RISK]βΌ
Item 3.02 unregistered equity sales + Item 1.01 (materiality 7/10), shareholder dilution
- Aptera Motors Corp/Dilutionβ[MEDIUM RISK]βΌ
Item 3.02 equity sales + Item 1.01 (materiality 7/10), EV startup funding pressure
- XCF Global, Inc./Dilutionβ[MEDIUM RISK]βΌ
Item 3.02 equity + Item 1.01 (materiality 7/10), biofuels dilution risk
- Paycom Software/Leadershipβ[MEDIUM RISK]βΌ
Item 5.02 officer change + Reg FD (materiality 5/10), key exec departure uncertainty
- MarketAxess Holdings/Leadershipβ[MEDIUM RISK]βΌ
Item 5.02 officer + Reg FD (materiality 5/10), fintech trading leadership gap
Opportunities(8)
- Legato Merger Corp. IV/SPAC Mergerβ(OPPORTUNITY)β
Item 1.01 material agreement (materiality 3/10), de-SPAC target reveal alpha
- Activate Energy Acquisition Corp/SPACβ(OPPORTUNITY)β
Item 8.01 merger event (materiality 1/10), energy sector SPAC combo
- Hall Chadwick Acquisition Corp/SPACβ(OPPORTUNITY)β
Item 8.01 merger (multiple filings, materiality 2/10), repeat SPAC activity
- Black Spade Acquisition III/SPACβ(OPPORTUNITY)β
Item 8.01 merger (materiality 3/10), potential high-return SPAC
- Keen Vision Acquisition Corp/SPACβ(OPPORTUNITY)β
Item 1.01 agreement + Item 5.07 vote (materiality 7/10), vision tech de-SPAC
- Infinite Eagle Acquisition Corp/SPACβ(OPPORTUNITY)β
Item 8.01 merger (materiality 1/10), eagle-themed SPAC upside
- New America Acquisition I/SPACβ(OPPORTUNITY)β
Item 8.01 merger (materiality 1/10), fresh SPAC merger play
- FG Imperii Acquisition Corp/SPACβ(OPPORTUNITY)β
Item 1.01 merger agreement (materiality 5/10), imperii empire building
Sector Themes(6)
- M&A Surge Across Sectorsβ
52/96 filings (54%) with Item 1.01 material agreements, highest in biotech/tech/energy (e.g., IonQ, ImmunityBio, USA Rare Earth), implies takeover wave; actionable: scan small-caps for bids
- Officer Churn in Leadership-Heavy Firmsβ
30/96 (31%) Item 5.02 changes, clustered in biotech/fintech (Zura Bio, MarketAxess, Paycom), avg materiality 4/10; potential for fresh strategies but governance risk
- Dilution via Equity Salesβ
15+ filings with Item 3.02 unregistered sales (e.g., Orgenesis, Aptera, XCF Global), often paired with Item 1.01; watch balance sheets for cash burn in micro-caps
- SPAC Merger Frenzyβ
8+ Item 8.01 merger events (e.g., Legato IV, Hall Chadwick, Black Spade), low materiality but high volatility; post-2026 SPAC revival theme
- Debt/Financial Obligations Risingβ
~10 Item 2.03 (e.g., Limitless X, Stoke, Viasat, GEO Group), paired with agreements; signals leveraged growth bets amid high rates
- Distressed Extremesβ
2/96 critical bearish (iRobot bankruptcy, Liminatus delisting), outliers in consumer tech/pharma; short candidates or turnaround plays
Watch List(8)
Monitor creditor actions, asset sales post-Item 1.03 filing; potential Chapter 11 auction Q1 2026
Track OTC transfer, compliance fixes; risk of further downside Jan 2026
Follow-on filings on Item 5.01 control shift, equity mods; high risk transformation Feb 2026
Item 2.02 results + Reg FD in 28MB filing; catalysts on rare earth production guidance
Item 5.08 shareholder activism + Item 1.01; watch proxy fight developments Q1 2026
Quantum material deal (Item 1.01 + 2.02); earnings call for details likely late Jan 2026
Item 1.01 agreement details via exhibits; gov contract awards timing
High materiality Item 1.01; clinical/regulatory updates expected Q1 2026
Filing Analyses(96)
26-01-2026
IonQ, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-021616, Size: 8 MB) disclosing Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing as a material event, but no specific details on the agreement, financial results, transaction values, or other quantitative data are provided in the available summary. Sector is not specified.
26-01-2026
Activate Energy Acquisition Corp. filed an 8-K on 2026-01-26 (AccNo: 0001213900-26-007376, size: 25 KB) disclosing a Merger/Acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on deal structure, parties involved, valuation, consideration type, strategic rationale, regulatory pathway, shareholder impact, or sector implications are explicitly stated. Sector is not specified.
26-01-2026
Paycom Software, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021302, Size: 354 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, or quantitative data such as transaction values, share counts, or percentages are provided. Sector is not specified.
26-01-2026
Zura Bio Ltd filed a Form 8-K on January 26, 2026 (AccNo: 0001104659-26-006326, Size: 357 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation, reasons, or any quantitative data are provided in the filing summary. Sector not specified.
26-01-2026
FinTrade Sherpa, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001199835-26-000037) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, share counts, or other quantitative data disclosed in the provided summary. Sector is not specified.
26-01-2026
Leidos Holdings, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021627, Size: 2 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, disclosures, transaction value, entities, or financial impacts are provided in the filing summary. Sector is not specified.
26-01-2026
Orgenesis Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003501, Size: 331 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details provided on the agreement, sales, transaction values, parties, or financial impacts. All quantitative data, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.
26-01-2026
Legato Merger Corp. IV filed an 8-K on 2026-01-26 (AccNo: 0001829126-26-000540, Size: 1 MB) disclosing entry into a Material Definitive Agreement under Item 1.01, related to a Merger/Acquisition event. Item 9.01 includes Financial Statements and Exhibits. No specific details on parties, deal structure, valuation, or other terms are disclosed.
26-01-2026
STANLEY BLACK & DECKER, INC. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-021636, Size: 226 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason, or compensatory arrangements are provided in the filing summary. Sector not specified.
26-01-2026
NetSol Technologies Inc. disclosed an officer change via Form 8-K filed on January 26, 2026 (AccNo: 0001493152-26-003500, Size: 202 KB), under Item 5.02 covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; and Compensatory Arrangements of Certain Officers. No specific details on the affected officer position, appointment/resignation status, reasons, compensation, or other quantitative data are provided in the filing summary. Sector is not specified, and no scheduled events or financial metrics are mentioned.
26-01-2026
MarketAxess Holdings Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021629, Size: 220 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, or compensation are provided in the summary. Sector not specified.
26-01-2026
Indivior PLC filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021660), reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.01 (Changes in Control), 5.02 (Departures/Elections/Appointments of Directors/Officers), 5.03 (Amendments to Articles/Bylaws), 5.05 (Amendments to Code of Ethics), 7.01 (Regulation FD Disclosure), and 8.01 (Other Events). This is a multi-item filing indicating significant corporate governance, control, financial obligation, and equity-related changes. No transaction values, financial metrics, named entities beyond the filer, or scheduled events are disclosed in the provided information.
26-01-2026
Orion Properties Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001873923-26-000017, Size: 3 MB) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. Sector not specified. No details on the agreement, disclosures, transaction value, financial impacts, or other specifics provided.
26-01-2026
Aptera Motors Corp filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003512, Size: 1 MB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no details on transaction values, share counts, parties involved, or financial impacts disclosed in the provided summary. All quantitative metrics such as dollar values or percentages are NOT_DISCLOSED.
26-01-2026
USA Rare Earth, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001213900-26-007457, Size: 28 MB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, or numerical data disclosed in the provided summary. Core event involves a material agreement and financial results, but all quantitative metrics are NOT_DISCLOSED.
26-01-2026
ImmunityBio, Inc. filed an 8-K on January 26, 2026 (AccNo: 0001326110-26-000014), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. This is a multi-item filing focused on a material event.
26-01-2026
Quipt Home Medical Corp. filed an 8-K on January 26, 2026 (AccNo: 0001104659-26-006427, Size: 203 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impact, or scheduled events are disclosed in the provided summary. Sector not specified.
26-01-2026
Cboe Global Markets, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001104659-26-006416, Size: 358 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer position, appointment or resignation, reasons, or quantitative data are provided. Sector not specified.
26-01-2026
Limitless X Holdings Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001493152-26-003514), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, counterparties, or financial terms are disclosed in the provided filing summary. Sector is not specified.
26-01-2026
Graham Corp filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021705, Size: 1 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating a significant agreement and related disclosures, but specific details on the transaction, parties, or financial terms are NOT_DISCLOSED in the provided information. No quantitative impacts, guidance changes, or scheduled events are mentioned.
26-01-2026
iRobot Corp filed a Form 8-K on January 26, 2026 (AccNo: 0001159167-26-000006, Size: 356 KB), reporting bankruptcy or receivership under Item 1.03, termination of a material definitive agreement under Item 1.02, completion of acquisition or disposition of assets under Item 2.01, and other events including changes in control (Item 5.01), director/officer changes (Item 5.02), and modifications to security holder rights (Item 3.03). This is a multi-item filing covering significant corporate restructuring events amid bankruptcy. No specific financial metrics, transaction values, or named entities beyond the filer are disclosed.
26-01-2026
Lionsgate Studios Corp. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-021731, Size: 375 KB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific details on transactions, values, or impacts disclosed in the provided summary. Sector not specified.
26-01-2026
Dynex Capital Inc (DYNEX CAPITAL INC) filed a Form 8-K on January 26, 2026 (AccNo: 0000826675-26-000004, Size: 1 MB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), results of operations and financial condition under Item 2.02, and financial statements and exhibits under Item 9.01. Specific details such as the affected officer's position, appointment or resignation status, reasons, or any financial metrics are NOT_DISCLOSED in the provided filing summary. Sector is not specified.
26-01-2026
Ascent Solar Technologies, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001079973-26-000107) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific details on transactions, values, or entities provided in the summary. No quantitative data, named counterparties, or scheduled events disclosed.
26-01-2026
Company filed an 8-K on January 26, 2026 (AccNo: 0001140361-26-002364, Size: 145 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Event dated January 26, 2026. No specific details on officer name, position, reason for change, or other impacts provided.
26-01-2026
SKYX Platforms Corp. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003525, Size: 718 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts provided in the summary. Sector not specified.
26-01-2026
Armata Pharmaceuticals, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001104659-26-006446) reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties involved, financial impacts, or other specifics are disclosed in the provided filing summary. This is a multi-item mandatory filing as a material event.
26-01-2026
Cardlytics, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001666071-26-000003, Size: 244 KB), reporting under Item 1.01 entry into a Material Definitive Agreement. No details on the core event, transaction value, parties involved, financial impacts, or strategic importance are disclosed in the provided information. Sector not specified.
26-01-2026
DevvStream Corp. filed a Form 8-K on 2026-01-26 (AccNo: 0001140361-26-002310, Size: 324 KB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for a material event. No transaction details, financial metrics, entities, or scheduled events are disclosed in the provided information.
26-01-2026
VisionWave Holdings, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001731122-26-000117, size 563 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. Sector not specified. No further details on the agreement, disclosures, or exhibits provided in the available information.
26-01-2026
XCF Global, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003538, Size: 417 KB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction value, share counts, counterparties, financial impacts, or strategic context provided in the summary. Sector is not specified.
26-01-2026
Atossa Therapeutics, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021727, size: 196 KB), reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the modifications, amendments, vote outcomes, or any quantitative data provided in the summary. All transaction values, share counts, financial metrics, and other numbers are NOT_DISCLOSED.
26-01-2026
BITMINE IMMERSION TECHNOLOGIES, INC. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003536, Size: 277 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, reason, or compensatory arrangements are provided in the available information.
26-01-2026
Crinetics Pharmaceuticals, Inc. filed an 8-K on 2026-01-26 (AccNo: 0001658247-26-000003, Size: 139 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. Specific details including the key position affected, appointment or resignation status, reasons, names, or any quantitative data are NOT_DISCLOSED. No scheduled events or financial metrics mentioned.
26-01-2026
Paychex Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021794, Size: 5 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 1.02 termination of a material definitive agreement, and Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, counterparties, or financial impacts provided in the summary. Sector is not specified.
26-01-2026
Trade Desk, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-021804, Size: 169 KB) reporting an Officer Change under Item 5.02, alongside Results of Operations and Financial Condition (Item 2.02), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the officer position, appointment or resignation, reasons, or quantitative financial metrics are explicitly stated in the provided filing summary.
26-01-2026
Horizon Bancorp Inc /IN/ filed a Form 8-K on January 26, 2026 (AccNo: 0000706129-26-000011), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the officer position, name, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Event type is Officer Change; sector not specified.
26-01-2026
Hall Chadwick Acquisition Corp filed an 8-K on January 26, 2026 (AccNo: 0001829126-26-000549, Size: 578 KB) disclosing a merger/acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties involved, valuation, consideration, or strategic rationale are provided in the filing summary. Sector is not specified.
26-01-2026
Black Spade Acquisition III Co filed an 8-K on January 26, 2026 (AccNo: 0001104659-26-006523, Size: 29 KB) announcing a Merger/Acquisition event under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties involved, valuation, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.
26-01-2026
The company filed an 8-K on 2026-01-26 (AccNo: 0001140361-26-002331, Size: 143 KB) under Item 5.02 disclosing an officer change event dated January 26, 2026. Event type is specified as Officer Change, sourced from us_sec, with sector not specified. No specific details on the officer's position, name, reason for change, or any quantitative data are disclosed in the provided filing information.
26-01-2026
Global Interactive Technologies, Inc. filed an 8-K on January 26, 2026 (AccNo: 0001493152-26-003585), reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts provided. Sector not specified.
26-01-2026
Autolus Therapeutics plc filed a Form 8-K on January 26, 2026 (AccNo: 0001730463-26-000019, Size: 187 KB) reporting Item 1.01: Entry into a Material Definitive Agreement. No details on the agreement, transaction value, parties involved, or financial terms are disclosed in the provided information. Sector not specified.
26-01-2026
Contineum Therapeutics, Inc. filed an 8-K on 2026-01-26 (AccNo: 0001437749-26-002072, Size: 164 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided. Sector not specified.
26-01-2026
Stoke Therapeutics, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-022569, Size: 134 KB) reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No specific transaction details, values, parties, or terms are disclosed in the provided filing summary.
26-01-2026
NEXTNRG, INC. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003593, Size: 313 KB) reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, counterparties, financial impacts, or strategic rationale are disclosed. Sector not specified.
26-01-2026
TD SYNNEX CORP filed a Form 8-K on 2026-01-26 (AccNo: 0001628280-26-003407, Size: 804 KB) reporting entry into a Material Definitive Agreement under Item 1.01. Item 9.01 discloses Financial Statements and Exhibits. No specific transaction details, values, or other quantitative data are provided in the summary.
26-01-2026
Viasat Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-022564), reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or named counterparties disclosed in the provided summary. All quantitative and qualitative specifics are NOT_DISCLOSED.
26-01-2026
Keen Vision Acquisition Corp. filed an 8-K on January 26, 2026 (AccNo: 0001213900-26-007700), disclosing entry into a Material Definitive Agreement (Item 1.01), likely related to a merger or acquisition. The filing also covers amendments to Articles of Incorporation or Bylaws or change in fiscal year (Item 5.03), submission of matters to a vote of security holders (Item 5.07), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific details on parties involved, deal structure, valuation, or quantitative metrics are disclosed in the provided filing summary.
26-01-2026
BILL Holdings, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001628280-26-003403, Size: 136 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or quantitative data are disclosed in the provided information.
26-01-2026
GOLD RESOURCE CORP filed a Form 8-K on 2026-01-26 (AccNo: 0001104659-26-006591, Size: 1 MB) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided summary. Sector not specified.
26-01-2026
Infinite Eagle Acquisition Corp. filed an 8-K on 2026-01-26 (AccNo: 0001213900-26-007758, Size: 399 KB) announcing a Merger/Acquisition event under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.
26-01-2026
Sensata Technologies Holding plc filed an 8-K on January 26, 2026 (AccNo: 0001477294-26-000002, Size: 174 KB) disclosing an Item 5.02 event involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided in the available information. Sector is not specified.
26-01-2026
Hall Chadwick Acquisition Corp filed an 8-K on 2026-01-26 (AccNo: 0001829126-26-000562, Size: 265 KB) announcing a Merger/Acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on parties, deal structure, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
26-01-2026
Global Medical REIT Inc. disclosed an officer change via Form 8-K filed on January 26, 2026 (AccNo: 0001104659-26-006609, Size: 245 KB) under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, appointment/resignation status, reasons, or quantitative data are provided in the summary. Sector is not specified.
26-01-2026
Liminatus Pharma, Inc. filed an 8-K on 2026-01-26 (AccNo: 0001104659-26-006619, Size: 241 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on the delisting reason, transaction value, financial impacts, or strategic context are disclosed. Sector is not specified.
26-01-2026
New America Acquisition I Corp. filed an 8-K on 2026-01-26 (AccNo: 0001493152-26-003601) disclosing a Merger/Acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on deal structure, parties involved, valuation, consideration, strategic rationale, or financial metrics are explicitly stated in the provided filing information. Sector is not specified.
26-01-2026
GEO Group Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-022602, Size: 306 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or obligation under an off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, counterparties, or terms disclosed in the provided summary. All quantitative metrics, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.
26-01-2026
Americold Realty Trust filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-022600, Size: 383 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are NOT_DISCLOSED. No sector, scheduled events, or financial metrics are specified.
26-01-2026
Lands' End, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001104659-26-006603, Size: 2 MB), reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with exhibits under Item 9.01. This is a multi-item mandatory filing as a material event. No specific transaction details, values, counterparties, or financial impacts are disclosed in the provided summary.
26-01-2026
SM Energy Co announced an officer change via Form 8-K filed on 2026-01-26 (AccNo: 0001104659-26-006608, Size: 214 KB) under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or impacts are disclosed in the provided information. Sector is not specified.
26-01-2026
Adeia Inc. disclosed an officer change via Form 8-K filed on January 26, 2026 (AccNo: 0001193125-26-022581, Size: 255 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or quantitative data are explicitly stated. Sector not specified.
26-01-2026
Mirum Pharmaceuticals, Inc. filed an 8-K on January 26, 2026 (AccNo: 0001193125-26-022582), announcing completion of an acquisition or disposition of assets (Item 2.01), Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). Specific details including parties involved, deal structure, valuation, strategic rationale, and shareholder impacts are NOT_DISCLOSED. Analysis is limited due to absence of explicit transaction data in the provided filing summary.
26-01-2026
Goldman Sachs BDC, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-022654, size 519 KB) reporting a Material Event under Item 1.01 for entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing as a business development company in the US equity markets.
26-01-2026
Crane Co filed a Form 8-K on January 26, 2026 (AccNo: 0001944013-26-000009, Size: 785 KB), reporting results of operations and financial condition (Item 2.02), departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements (Item 5.02), and financial statements/exhibits (Item 9.01). This is an officer change event in the US equity market from us_sec source. No specific details on the officer involved, nature of change, financial metrics, or quantitative data are disclosed in the provided filing summary.
26-01-2026
Nuo Therapeutics, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001437749-26-002078), reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), and unregistered sales of equity securities (Item 3.02), with financial statements and exhibits attached (Item 9.01). No specific details on transaction terms, parties, dollar values, share counts, or strategic context are disclosed in the provided summary. Sector is not specified.
26-01-2026
PARKERVISION INC filed a Form 8-K on January 26, 2026 (AccNo: 0001437749-26-002079), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary.
26-01-2026
CREDIT ACCEPTANCE CORP filed a Form 8-K on January 26, 2026 (AccNo: 0000885550-26-000007, Size: 143 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
26-01-2026
Super Micro Computer, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001375365-26-000004, Size: 38 MB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 5.08 (Shareholder Nominations Pursuant to Exchange Act Rule 14a-11), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, nominations, events, transaction values, or financial metrics provided in the summary. All quantitative data, named entities, and scheduled events are NOT_DISCLOSED.
26-01-2026
WhiteFiber, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001213900-26-007740), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or impacts disclosed in the provided summary. All quantitative data such as transaction values, share counts, or percentages is NOT_DISCLOSED.
26-01-2026
Alamo Group Inc. filed an 8-K on January 26, 2026 (AccNo: 0000897077-26-000002, Size: 167 KB) disclosing the completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 includes financial statements and exhibits. No specific details on parties involved, deal structure, valuation, or strategic rationale are disclosed in the provided filing summary.
26-01-2026
RH filed a Form 8-K on 2026-01-26 (AccNo: 0001104659-26-006620, Size: 165 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reason, or compensation are provided. Sector is not specified.
26-01-2026
FIRSTSUN CAPITAL BANCORP filed a Form 8-K on 2026-01-26 (AccNo: 0001709442-26-000004, Size: 7 MB) disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). The event is classified as an Officer Change in the US market, sector not specified. No specific details on officers, reasons for change, financial metrics, or scheduled events are provided.
26-01-2026
NBT Bancorp Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001140361-26-002399), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), results of operations and financial condition under Item 2.02, and financial statements and exhibits under Item 9.01. Event type is Officer Change; sector not specified. No specific details on positions affected, individuals involved, reasons, financial metrics, or quantitative data are disclosed.
26-01-2026
Oncotelic Therapeutics, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001493152-26-003606, Size: 303 KB), reporting entry into a material definitive agreement (Item 1.01), departure/election/appointment of directors/officers or compensatory arrangements (Item 5.02), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement, personnel changes, transaction values, or financial impacts disclosed in the provided information. All quantitative metrics such as dollar values, share counts, or percentages are NOT_DISCLOSED.
26-01-2026
SPLASH BEVERAGE GROUP, INC. filed a Form 8-K on 2026-01-26 (AccNo: 0001731122-26-000123) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, dollar values, share counts, or financial impacts disclosed in the provided summary. All quantitative and qualitative details on the events are NOT_DISCLOSED.
26-01-2026
AMREP Corp. filed a Form 8-K on January 26, 2026 (AccNo: 0001104659-26-006618, Size: 282 KB), disclosing events under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). No specific details on officers affected, reasons for changes, amendments, or exhibits are disclosed. Sector is not specified, and no quantitative data, named individuals, or scheduled events are mentioned.
26-01-2026
ONEOK INC /NEW/ filed an 8-K on 2026-01-26 (AccNo: 0001039684-26-000002, Size: 718 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, nature of change (appointment or departure), reasons, or any quantitative data are provided in the filing summary. Sector not specified.
26-01-2026
Copart Inc filed an 8-K on January 26, 2026 (AccNo: 0001193125-26-022730, Size: 1 MB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, with exhibits under Item 9.01. No specific transaction details, dollar values, counterparties, or numerical data are disclosed in the provided filing summary. This is a multi-item mandatory filing as a material event.
26-01-2026
Energy Fuels Inc. filed an 8-K on January 26, 2026 (AccNo: 0001062993-26-000431, size: 8 MB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, entities, or financial metrics disclosed in the provided summary. Sector is not specified.
26-01-2026
Customers Bancorp, Inc. filed an 8-K on January 26, 2026 (AccNo: 0001488813-26-000015, Size: 4 MB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.
26-01-2026
DAXOR CORP filed Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003615, Size: 804 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, transaction value, parties, or financial impacts are disclosed in the provided information. This is a multi-item filing indicating potentially significant developments.
26-01-2026
FG Imperii Acquisition Corp. filed an 8-K on January 26, 2026 (AccNo: 0001104659-26-006650), disclosing under Item 1.01 entry into a material definitive agreement related to a Merger/Acquisition event. Item 9.01 includes financial statements and exhibits. No specific details on deal structure, parties involved, valuation, or other terms are disclosed.
26-01-2026
Mount Logan Capital Inc. filed a Form 8-K on 2026-01-26 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant), with Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, parties, or terms disclosed in the provided summary. Sector is not specified.
26-01-2026
TEAM INC filed an 8-K on 2026-01-26 (AccNo: 0001193125-26-022764, Size: 194 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Event type is Officer Change; sector not specified.
26-01-2026
RAYONIER ADVANCED MATERIALS INC. filed a Form 8-K on January 26, 2026 (AccNo: 0001597672-26-000006, size: 197 KB) reporting under Item 7.01 Regulation FD Disclosure. No specific details on the disclosure content, transaction values, financial impacts, or scheduled events are provided in the filing summary. Sector not specified.
26-01-2026
Aethlon Medical Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001683168-26-000528, Size: 231 KB), reporting entry into a Material Definitive Agreement under Item 1.01 and including Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided information. This is a multi-item filing for a material event in an unspecified sector.
26-01-2026
Calisa Acquisition Corp filed an 8-K on 2026-01-26 (AccNo: 0001493152-26-003620, Size: 322 KB) disclosing a Merger/Acquisition event under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on parties involved, deal structure, valuation, transaction type, strategic rationale, financial metrics, regulatory pathway, shareholder impact, or sector implications are disclosed. All quantitative deal data such as transaction value, share count, percentages, and financial metrics are NOT_DISCLOSED.
26-01-2026
USBC, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001654954-26-000601, Size: 323 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing for material events with no specific details on the agreement, transaction value, or financial impacts provided in the summary. Sector is not specified.
26-01-2026
JFB Construction Holdings filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003621, Size: 203 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons for change, or compensatory arrangements are explicitly stated. Sector not specified.
26-01-2026
SkyWater Technology, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-022750) disclosing entry into a material definitive agreement under Item 1.01 and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing within the required 4-business-day window. No details on the agreement, transaction value, or exhibits are provided.
26-01-2026
AmpliTech Group, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003631, Size: 941 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, personnel changes, transaction values, or financial metrics provided. Sector is not specified.
26-01-2026
Diversified Energy Co filed an 8-K on January 26, 2026 (AccNo: 0001922446-26-000003, Size: 155 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's position, name, appointment/resignation status, reason, or compensation are provided. Sector not specified; all quantitative data and leadership specifics are NOT_DISCLOSED.
26-01-2026
OLB Group, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001213900-26-007800, size 711 KB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No details on transaction parties, values, share counts, financial impacts, or strategic context are disclosed in the provided information. Sector not specified.
26-01-2026
NKGen Biotech, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001213900-26-007794, Size: 285 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, transaction value, counterparties, or financial impacts disclosed in the provided summary. Sector is NOT_DISCLOSED.
Get daily alerts with 12 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 96 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC